+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CAPLIPOINT

Caplin Point Laboratories Share Price

₹2,795.40 +72.3 (2.66%)
New 52W High in past week

10 Sep, 2026 3:59 PM (IST)

Caplin Point Laboratories live price: ₹2,795.40. It opened at ₹2,716 vs previous close ₹2,723; intraday high/low: ₹2,840/₹2,714. The 50 & 200 DMA stand at ₹2,558.50/₹2,212.00.

Caplin Point Laboratories Performance

  • Today's Low
  • ₹2,714
  • Today's High
  • ₹2,840
  • 52 Week Low
  • ₹1,500
  • 52 Week High
  • ₹2,877
  • Open Price₹2,716
  • Previous Close₹2,723
  • Volume265,933
  • 50 DMA₹2,558.50
  • 100 DMA₹2,390.30
  • 200 DMA₹2,212.00

Caplin Point Laboratories Chart

Investment Returns

  • Over 1 Month + 8.6%
  • Over 3 Month + 23.95%
  • Over 6 Month + 67.33%
  • Over 1 Year + 26.84%

Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!

Invest Now

Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.9
  • PEG Ratio
  • 1.8
  • Market Cap Cr
  • 21,248
  • P/B Ratio
  • 5.6
  • Average True Range
  • 99
  • EPS
  • 87.5
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 67.5
  • RSI
  • 62.55
  • MFI
  • 87.15

Latest Stock News Updates

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for Notice of 35th AGM and E-Voting Information

Caplin Point Laboratories Ltd - 524742 - Letter To Shareholders

Letter to Shareholders regarding dispatch of 35th AGM Notice and Annual Report for the Financial year 2025-26

Caplin Point Laboratories Ltd - 524742 - Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for the Financial Year 2025-26

Caplin Point Laboratories Financials

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹2,795.40
+ 72.3 (2.66%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,665.70
  • 50 Day
  • ₹2,558.50
  • 100 Day
  • ₹2,390.30
  • 200 Day
  • ₹2,212.00

Resistance and Support

2782.97 Pivot Speed
  • R3 2,977.40
  • R2 2,908.50
  • R1 2,851.90
  • S1 2,726.40
  • S2 2,657.50
  • S3 2,600.90

Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results & Final Dividend
2026-05-14 Audited Results & Interim Dividend
2026-02-05 Quarterly Results
2025-11-05 Quarterly Results
2025-08-07 Quarterly Results, Final Dividend & A.G.M.
Date Purpose Remarks
2026-09-18 FINAL Rs.4.00 per share(200%)Final Dividend
2026-05-30 INTERIM Rs.4.00 per share(200%)Interim Dividend
2025-09-12 FINAL Rs.3.00 per share(150%)Final Dividend
2025-05-30 INTERIM Rs.3.00 per share(150%)Interim Dividend
2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
View Caplin Point Laboratories Dividend History Arrow
Date Purpose Remarks
2016-10-20 Split

Caplin Point Laboratories Shareholding Pattern

70.57%
21.19%
5.76%
2.03%
0.46%

About Caplin Point Laboratories

Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations. View More
  • NSE Symbol
  • CAPLIPOINT
  • BSE Symbol
  • 524742
  • ISIN
  • INE475E01026

Similar Stocks to Caplin Point Laboratories

Caplin Point Laboratories FAQs

Caplin Point Laboratories share price is ₹2,795 As on 11 September, 2026 | 01:59

The Market Cap of Caplin Point Laboratories is ₹21248.3 Cr As on 11 September, 2026 | 01:59

The P/E ratio of Caplin Point Laboratories is 31.9 As on 11 September, 2026 | 01:59

The PB ratio of Caplin Point Laboratories is 5.6 As on 11 September, 2026 | 01:59

The 52 week High & Low of Caplin Point Laboratories is ₹2877.3/₹1500.3 respectively As on 11 September, 2026 | 01:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23